Featured Expert: Shannon Cope
This month PRECISIONheor would like to highlight the work and expertise of Vice President Shannon Cope.
This month PRECISIONheor would like to highlight the work and expertise of Vice President Shannon Cope.
Are you involved in preparing health technology assessment (HTA) submissions and in early health economic modeling as part of drug development decision-making? You won't want to miss our webinar, "Cost-Effectiveness Analysis with R? A Discussion." Learn about the pros and cons of R versus Excel in preparing HTA submissions, and the acceptability of R by HTA agencies.
Recently, the National Institute for Health and Care Excellence (NICE) published a detailed strategy plan, outlining its vision during the next five years. Included in this report are new guidelines for technology evaluation, evidence standards, guidance adoption, and real-world data and research, which are applicable to all stakeholders, including the life science industry, regulators, healthcare providers, patients, and the public.
This month PRECISIONheor would like to highlight the work and expertise of Senior Director Steve Sison.
Join us for a new Precision webinar in partnership with MedStar Health, a nationally-recognized leader in the integration and application of real world data analytics.
This month PRECISIONheor would like to highlight the work and expertise of Senior Principal Scientist Suepattra May-Slater.
Planning on attending Virtual ISPOR EU 30 November - 3 December? PRECISIONheor is excited to be participating and will be presenting a number of insightful posters and presentations.
This month PRECISIONheor would like to highlight the work and expertise of Senior Director Meena Venkatachalam.
Don't miss PRECISIONheor's Sajjad Raza in this on-demand webinar, hosted by Scientist.com and HealthEconomics.com, as part of their Cutting Edge Conversations series.
Quantitative studies are the gold standard for establishing causality and drawing conclusions that can be generalized beyond the population studied. However, quantitative research methods also often lack contextual considerations and perspectives that can be further informed by qualitative approaches.
The Precision Value & Health family of brands is now Precision AQ
Precision AQ helps life sciences companies navigate the complexities of commercialization across a product’s lifecycle. Our team is comprised of experts, advisors, and creators working to ensure patients have access to life-changing medicines.
Our global offerings include:
Our name, which stands for Precision Access Quotient, reflects our approach to removing barriers – fusing together science (IQ, or Intelligence Quotient) and empathy (EQ, or Emotional Quotient). The result is “AQ: Access Quotient”, a critical ingredient in navigating the therapy-to-patient journey informed by data-driven analytics and insights.
To find out more about our global services and our unified mission, empowering access to life-changing medicines for all, visit: Precision AQ